RUNX1 promotes CRC metastasis through the induction of Wnt/β-catenin signaling and the EMT [74], while cinobufacini can inhibit CRC invasion and metastasis by inhibiting the Wnt/β-catenin–EMT pathway [75]. The gene discussed is RUNX1; the disease is colorectal carcinoma.